Isolation effectively prevents the transmission of hepatitis C virus in the hemodialysis unit

Journal of the Formosan Medical Association

Volumn 102, Issue 2, 2003, Pages 79-85

  Yang, Chwei Shiun ^a,b   Chang, Hsu Hung ^c   Chou, Chia Chi ^c   Peng, Sheng Jeng ^c  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c CATHAY GENERAL HOSPITAL   (Taiwan)

Author keywords

Hepatitis C; Infection control; Patient isolation; Renal dialysis

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; VIRUS ANTIBODY;

ADULT; AGED; ARTICLE; ARTIFICIAL KIDNEY; CONTROLLED STUDY; FEMALE; HEALTH CARE POLICY; HEMODIALYSIS; HEPATITIS B; HEPATITIS C; HEPATITIS C VIRUS; HOSPITAL HYGIENE; HUMAN; INCIDENCE; INFECTION CONTROL; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PREVALENCE; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; SEROCONVERSION; VIRUS TRANSMISSION;

FEMALE; HEMODIALYSIS UNITS, HOSPITAL; HEPACIVIRUS; HEPATITIS C; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PATIENT ISOLATION; PREVALENCE; RETROSPECTIVE STUDIES; TAIWAN;

EID: 0037628219     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Jadoul M: Transmission routes of HCV infection in dialysis. Nephrol Dial Transplant 1996;11(Suppl 4):36-8.
2. Huang CS, Ho MS, Yang CS, et al: Hepatitis C marker in hemodialysis patients. J Clin Microbiol 1993;31:1764-9.
3. Hung KY, Chen WY, Yang CS, et al: Hepatitis B and C in hemodialysis patients. Dial Transplant 1995;24:135-9.
4. Forms X, Fernandez-Llama P, Pons M, et al: Incidence and risk factors of hepatitis C infection in hemodialysis unit. Nephrol Dial transplant 1997;12;736-40.
5. Kobayashi M, Tanaka E, Oguchi H, et al: Prospective follow-up study of hepatitis C virus infection in patients undergoing maintenance hemodialysis: comparison among hemodialysis units. J Gastroenterol Hepatol 1998;13:604-9.
6. Pereira BJG, Levey AS: Hepatitis C virus infection in dialysis and renal transplantation. Kidney Int 1997;51:981-99.
7. Moyer LA, Alter MJ: Hepatitis C virus in hemodialysis setting: a review with recommendations for control. Semin Dialysis 1994; 7:124-7.
8. Niu MT, Coleman PH, Alter MJ: Multicenter study of hepatitis C virus infection in chronic hemodialysis center staff members. Am J Kidney Dis 1993;22:568-73.
9. Niu MT, Alter MJ, Christensen C, et al: Outbreak of hemodialysis associated nonA, nonB hepatitis and correlation with antibody to hepatitis C virus. Am J Kidney Dis 1992;19:345-52.
10. Le Pogam S, Le Chapois D, Christen R, et al: Hepatitis C in a hemodialysis unit: Molecular evidence for nosocomial transmission. J Clin Microbiol 1998;36:3040-3.
11. Izopet J, Pasquier C, Sandres K, et al: Molecular evidence for nosocomial transmission of hepatitis C virus in French Hemodialysis unit. J Med Virol 1999;58:139-44.
12. Irish DN, Blake C, Christophers J, et al: Identification of hepatitis C virus seroconversion resulting from nosocomial transmission on a hemodialysis unit: Implications for infection control and laboratory screening. J Med Virol 1999;59:135-140.
13. Gilli P, Soffritti S, De Paoli Vitali E, et al: Prevention of hepatitis C virus within dialysis units. Nephron 1995;70:301-6.
14. Jadoul M, Cornu CH, Van Ypersele de Strihou CH: The Universitaires Cliniques St-Luc (UCL) Collaborative Group. Universal precautions prevent hepatitis C virus transmission: a 54 month follow-up of Belgian multicenter study. Kidney Int 1998;53:1022-5.
15. Rais-Jalali G, Khajendehi P: Anti-HCV seropositivity among hemodialysis patients of Iranian origin. Nephrol Dial Transplant 1999; 14:2055-6.
16. Neves PL, Amorim JP: Should patients with hepatitis C virus antibodies in chronic hemodialysis be isolated [letter]? Am J Kidney Dis 1993;20:422
17. Jadoul M, Cornu C, van-Ypersele de Strihou C: UCL collaborative Group: Incidence and risk factors for hepatitis C seroconversion in hemodialysis. A prospective study. Kidney Int 1993;44: 1322-6.
18. Rothman KJ. Modern Epidemiology. Little, Brown and Company, 1986:170-172.
19. Tokars JI, Miller ER, Alter MJ, et al: National surveillance of dialysis associated disease in the United States. Semin Dial 2000;13: 75-85.
20. Donahue JG, Munoz A, Ness PM, et al: The declining risk of post-transfusion hepatitis C virus infection. N Engl J Med 1992; 327:369-73.
21. Simon N, Corouce AM, Lemarrec N, et al: A twelve year natural history of hepatitis C virus infection in hemodialysis patients. Kidney Int 1994;45:504-11.
22. Jadoul M: Epidemiology and mechanism of transmission of the hepatitis C virus in hemodialysis. Nephrol Dial Transplant 2000; 15(Suppl 8):39-41.
23. Conry-Cantilena C, Van Roden M, Gibble J, et al: Routes of infection, viremia and liver disease in blood donors found to have hepatitis C virus infection. New Engl J Med 1996;334: 1691-6.
24. Ho MS, Yang CS, Chen PJ, et al: Intrafamilial transmission of hepatitis C virus. J Clin Microbiol 1994;32:2824-6.
25. Beccari M, Romagnoni M, Rizzolo L, et al: Is isolation needed for anti-HCV-positive hemodialysis patients [letter]? Nephron 1996;72:372.
26. Jadoul M: Should hemodialysis patients with hepatitis C virus antibodies be isolated? Semin Dial 1995;8:1-3.
27. Kellerman S, Alter MJ: Preventing hepatitis B and hepatitis C virus infection in end-stage renal disease patients: back to basics. Hepatology 1999;29:291-3.
28. Blumberg A, Zehuder C, Burckhardt JJ: Prevention of hepatitis C infection in hemodialysis units: a prospective study. Nephrol Dial Transplant 1995;10:230-3.
29. dos Santos JP, Loureiro A, Cendoroglo Neto M, et al: Impact of dialysis room and reuse strategies on the incidence of hepatitis C virus infection in hemodialysis units. Nephrol Dial Transplant 1996;20:2017-22.
30. Izopet J, Rostaing L, Ton That H, et al: Incidence of HCV infection in hemodialysis units with or without patients isolation [abstract]. J Am Soc Nephrol 1995;6:537.
31. Okuda K, Hayashi H, Kobayashi S, et al: Mode of hepatitis C infection not associated with blood transfusion among chronic hemodialysis patients. J Hepatol 1995;23:28-31.
32. Gili P, Moretti M, Soffritti S, et al: Non-A, non-B hepatitis and anti-HCV antibodies in dialysis patients. Int J Artif Organs 1990; 13:737-41.
33. Jadoul M: Transmission routes of HCV infection in dialysis. Nephrol Dial Transplant 1996;11 (Suppl 4):36-8.
34. McLaughlin KJ, Cameron SO, Good T, et al: Nosocomial transmission of hepatitis C virus within a British dialysis center. Nephrol Dial Transplant 1997;12:304-9.
35. Lamballerie X, Olmer M, Bouchouareb D, et al: Nosocomial transmission of hepatitis C virus in hemodialysis patients. J Med Virol 1996;49:296-302.
36. Pujol FH, Ponce JG, Lema MC, et al: High incidence of hepatitis C virus infection in hemodialysis patients in units with high prevalence. J Clin Microbiol 1996;34:1633-6.
37. Petrosillo N, Gilli P, Serraino D, et al: The Collaborative Group: Prevalence of infected patients and understaffing have a role in hepatitis C virus transmission in dialysis. Am J Kidney Dis 2001; 37:1004-10.
38. Corcoran GD, Brinks NS, Millar CGM, et al: Hepatitis C virus infection in hemodialysis patients: a clinical and virological study. J Infect 1994;28:279-85.
39. Sampietro M, Badalamenti S, Salvadori S, et al: High prevalence of a rare hepatitis C virus in patients treated in the same hemodialysis unit: evidence for nosocomial transmission of HCV. Kidney Int 1995;47:911-7.
40. Arenas Jiménez MD, Sánchez-Payá J, Gonzales C, et al: Audit on the degree of application of universal precautions in a hemodialysis unit. Nephrol Dial Transplant 1999;14:1001-3.
41. Schneeberger PM, Toonen N, Keur I, et al: Infection control of hepatitis C in Dutch dialysis centres. Nephrol Dial Transplant 1998;13:3037-40.
42. Arenas Jiménez D, Sánchez-Paya J, González C, et al: Isolation of HCV patient is efficient in reducing the annual incidence of HCV infection, but is it really necessary? Nephrol Dial Transplant 1999;14:1337-9.